Filing Details

Accession Number:
0001140361-13-014606
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2013-03-29 17:12:18
Reporting Period:
2012-10-15
Filing Date:
2013-03-29
Accepted Time:
2013-03-29 17:12:18
Original Submission Date:
2012-10-17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
3116 Akorn Inc AKRX Pharmaceutical Preparations (2834) 720717400
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1466630 A Timothy Dick 1925 West Field Court Suite 300
Lake Forest IL 60045
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-10-15 54,900 $1.00 72,980 No 4 M Direct
Common Stock Disposition 2012-10-15 54,900 $12.71 18,080 No 4 S Direct
Common Stock Acquisiton 2012-10-16 45,100 $1.00 63,180 No 4 M Direct
Common Stock Disposition 2012-10-16 45,100 $13.00 18,080 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Footnotes
  1. Reflects the weighted average sale prices of the shares sold. The shares were sold in multiple trades at prices ranging from $12.6730 to $13.0335 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at separate prices within the foregoing range.
  2. Includes additional purchases of Akorn Common Stock through Akorn's Employee Stock Purchase Plan of 7,352 shares on October 1, 2009, 7,389 shares on January 4, 2010 and 4,118 shares on January 18, 2012.
  3. Reflects the weighted average sale prices of the shares sold. The shares were sold in multiple trades at prices ranging from $13.0000 to $13.0050 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at separate prices within the foregoing range.